Jynarque
Ended Awarded
- Contract number
- 36C26124N0726
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,581
Award facts
- Contract value 100% obligated
- $12,580.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on June 20, 2024, represents a $12,580.72 firm fixed-price contract for Jynarque (tolvaptan) pharmaceutical products issued to Otsuka America Pharmaceutical Inc. by the Department of Veterans Affairs' Veterans Integrated Service Network 21. The contract was awarded without set-aside designation under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for delivery to Potomac, Maryland, with an ultimate completion date of August 20, 2024. Jynarque is a specialized medication used to treat autosomal dominant polycystic kidney disease and hyponatremia, conditions requiring targeted pharmaceutical intervention within the VA's healthcare system.
This delivery order is issued under a larger Blanket Purchase Agreement valued at $83.3 million that Otsuka America Pharmaceutical Inc. maintains with the VA's National Acquisition Center, which has an ultimate completion date of March 26, 2026. The vendor also holds a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products. These standing agreements enable multiple VA Integrated Service Networks across the country to efficiently procure critical specialty pharmaceuticals for veteran populations, with the underlying contracts structured as firm fixed-price arrangements that streamline the procurement process for essential medications.
Quick answers
Who was awarded contract 36C26124N0726?
36C26124N0726 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on June 20, 2024.
How much is contract 36C26124N0726 worth?
The government has obligated $12,581 on 36C26124N0726.
Is contract 36C26124N0726 an order under another contract?
Yes. 36C26124N0726 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0726 competed?
The extent of competition for 36C26124N0726 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award